← Back
Data updated: Jun 28, 2026
ACETYLENE OXYGENE CO
Pharma Pharmaceuticals
ACETYLENE OXYGENE CO is a pharmaceutical company with 1 FDA-approved products.
2013
Since
1
Drugs
-
Trials
2
New Drugs (2yr)
Modality:
1 Small Molecules
ACETYLENE OXYGENE CO's Key Drugs
ACETYLENE OXYGENE CO's core commercial portfolio centers on MEDICAL AIR, USP — its most strategically important drugs approved in the last 15 years.
ACETYLENE OXYGENE CO's Recent FDA Approvals
ACETYLENE OXYGENE CO secured 2 new FDA approvals for novel drugs (NDA/BLA) in the last two years.
ACETYLENE OXYGENE CO's Therapeutic Areas
Disease areas where ACETYLENE OXYGENE CO has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
ACETYLENE OXYGENE CO Pipeline Snapshot
Active clinical trials for ACETYLENE OXYGENE CO across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • MEDICAL AIR, USP leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2013-09-01
- Latest
- 2013-09-01
- Applications
- 1